Isabelle Trouilloud - Concepedia

Author

Isabelle Trouilloud

Sorbonne Université

Also Known As

I Trouilloud, I. TROUILLOUD, I. Trouilloud, Isabelle Trouilloud, Martin Fuchs, TROUILLOUD, Isabelle

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Sorbonne Université Université Paris Cité Hôpital Saint-Antoine Hôpital Européen Georges-Pompidou Hôpital Privé Jean Mermo

About

Isabelle Trouilloud is an author at Sorbonne Université specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	412
2	Health Sciences	1	1	10
3	Biostatistics	1	1	32
4	Gastroenterology	1	1	167
5	Immunology	1	1	20

Isabelle Trouilloud

Publications

975

Citations

H-Index

Page 1

	Year	Citations
FOLFIRINOX for Locally Advanced Pancreatic Adenocarcinoma: Results of an AGEO Multicenter Prospective Observational Cohort Lysiane Marthey, António Sá Cunha, Jean‐Frédéric Blanc, Annals of Surgical Oncology Surgical OncologyPancreatic CancerGastrointestinal OncologyMedicineGastroenterology	2014	167
Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study David Tougeron, Guillaume Mouillet, Isabelle Trouilloud, JNCI Journal of the National Cancer Institute	2016	156
Second‐line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine‐platinum combination: A large multicenter study by the Association des Gastro‐Entérologues Oncologues Bertrand Brieau, Laëtitia Dahan, Yann De Rycke, Cancer	2015	118
Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort Daniel Pietrasz, Lysiane Marthey, Mathilde Wagner, Annals of Surgical Oncology Patients Secondary ResectedSurgical OncologyPancreatic CancerGastrointestinal OncologyMedicine	2015	80
Long‐term outcome of non‐fistulizing (ulcers, stricture) perianal Crohn’s disease in patients treated with infliximab Guillaume Bouguen, Isabelle Trouilloud, Laurent Siproudhis, Alimentary Pharmacology & Therapeutics	2009	67
Folfirinox <i>versus</i> gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study Nicolas Williet, Angélique Saint, Anne‐Laure Pointet, Therapeutic Advances in Gastroenterology	2019	67
FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study Aziz Zaanan, Isabelle Trouilloud, Theofano Markoutsaki, BMC Cancer	2014	39
Adalimumab for Crohn’s disease with intolerance or lost response to infliximab: a 3‐year single‐centre experience Abderrahim Oussalah, Abdenour Babouri, Jean‐Baptiste Chevaux, Alimentary Pharmacology & Therapeutics	2008	38
Fixed-dose rate gemcitabine alone or alternating with FOLFIRI.3 (irinotecan, leucovorin and fluorouracil) in the first-line treatment of patients with metastatic pancreatic adenocarcinoma: An AGEO randomised phase II study (FIRGEM) Isabelle Trouilloud, Anne-Claire Dupont-Gossard, David Malka, European Journal of Cancer OncologyPancreatic CancerGastrointestinal OncologyMetastatic Pancreatic AdenocarcinomaMedicine	2014	36
Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicentre study David Tougeron, Gaëlle Sickersen, Guillaume Mouillet, European Journal of Cancer MedicineMicrosatellite InstabilityEpidemiology Of CancerPathologyColorectal Cancer	2015	32

Page 1